Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03871348
Brief Title: A First-in-Human Dose Escalation and Expansion Study to Evaluate Intratumoral Administration of SAR441000 as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

First Submitted : January 24, 2019
First Submitted that Met QC Criteria : March 10, 2019
First Posted : March 12, 2019

Last Update Submitted that Met QC Criteria : March 10, 2019
Last Update Posted : March 12, 2019